StonvexLoading…
StonvexStonvexStonvexCore line items from FRPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $297.48M | $297.64M | $1.10B | $816.79M | $527.94M |
Operating Income | Not available | $4.33M | $75.67M | $31.21M | $6.31M |
Net Income | Not available | $48.51M | $139.14M | $105.32M | $3.66M |
EPS (Diluted) | $0.32 | $0.91 | $2.64 | $2.00 | $0.07 |
Total Assets | Not available | $1.84B | $1.78B | $1.75B | $1.65B |
Total Liabilities | Not available | $577.12M | $569.12M | $567.14M | $575.84M |
Cash & Equivalents | Not available | $381.38M | $277.98M | $274.59M | $243.68M |
Free Cash Flow OCF − CapEx | Not available | $12.73M | $12.38M | $10.32M | $-21.24M |
Shares Outstanding | Not available | 49.14M | 48.97M | 48.79M | 48.78M |